Kiniksa PharmaceuticalsKNSA 
$19.94-1.53%24h
-1.53%24h
Global rank9431
Market cap$706.07M
Change 7d-8.03%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Kiniksa Pharmaceuticals (KNSA)
As of January 2025, Kiniksa Pharmaceuticals has a market cap of $706.07M. This makes Kiniksa Pharmaceuticals the world's 9431th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Kiniksa Pharmaceuticals from 2018 to 2024
-
Value:-
Market cap history of Kiniksa Pharmaceuticals from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $717.05M | 15.45% |
| 2023 | $621.09M | 17.09% |
| 2022 | $530.44M | 27.27% |
| 2021 | $416.77M | -33.39% |
| 2020 | $625.69M | 59.76% |
| 2019 | $391.63M | -60.63% |
| 2018 | $994.66M | - |
KNSA Market Cap Today is $706.07M -1.53% - 10 Jan 2025
View largest stocks by market cap 
